HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Histopathology of post-embolized meningiomas.

Abstract
Although embolization of meningiomas has been performed for many years as a preoperative adjunct to reduce tumor vascularity and facilitate surgical excision, little has been written about the features of the histological artefacts introduced by the process. In particular, the fact that it may produce tumor necrosis may potentially cause confusion with atypical or malignant meningiomas. In this study, 25 meningeal tumors of different histological subtypes, all of which had been previously embolized, were reviewed histologically as well as with immunostaining for the MIBI antigen and proliferating cell nuclear antigen (PCNA). Necrosis, in the form of confluent necrosis as well as micronecrosis, was the most common feature (48%). Other characteristic features included florid ischemic changes (16%), intravascular Ivalon particles (24%), and fibrinoid necrosis of vascular walls (12%). Histological changes showed no obvious relationship with the interval between embolization and surgery. There was an increase in MIB1 and PCNA labelling indices in those tumor exhibiting necrotic foci, but it did not seem to have any prognostic significance. We believe pathologists should be familiar with the histological changes induced by embolization in meningiomas so that an erroneous diagnosis of a high-grade lesion will not be made.
AuthorsH K Ng, W S Poon, K Goh, M S Chan
JournalThe American journal of surgical pathology (Am J Surg Pathol) Vol. 20 Issue 10 Pg. 1224-30 (Oct 1996) ISSN: 0147-5185 [Print] United States
PMID8827029 (Publication Type: Journal Article)
Topics
  • Adult
  • Aged
  • Arteries (pathology)
  • Brain Neoplasms (blood supply, mortality, pathology, therapy)
  • Cell Nucleus (pathology)
  • Cytoplasm (pathology)
  • Embolization, Therapeutic
  • Female
  • Humans
  • Immunohistochemistry
  • Male
  • Meningioma (blood supply, mortality, pathology, therapy)
  • Middle Aged
  • Necrosis
  • Retrospective Studies

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: